trump glp-1 medicaid U.S. President Donald has said the government will provide drugs, used for weight loss and diabetes treatment, to Medicare beneficiaries starting July 1. The move is aimed at expanding access Trump admin mulls covering weight

The possible protective role of glucagon-like peptide 1 on endothelium during the meal and evidence for an "endothelial resistance" to glucagon-like peptide 1 in diabetes

Stringent cost and payer controls are a significant restraint in the GLP-1 drugs market due to the high prices associated with these therapies

The 2024 tirzepatide trial showed real reductions in AHI, weight, and blood pressure, with bigger benefits in patients with severe obesity and severe OSA

The weight trajectory matters

Most GLP-1 medications come with specific storage guidelines, typically: Before first use : Store pens in the refrigerator between 36F and 46F (2C to 8C)

Sandoz Biosimilar Pipeline Report